UHPLC-HRMS based flavonoid profiling of the aerial parts of Chenopodium foliosum Asch. (Amaranthaceae).
Zlatina Kokanova-NedialkovaParaskev T NedialkovPublished in: Natural product research (2019)
Chenopodium foliosum Asch. has been recognised by Bulgarian legislation as a medicinal plant. The decoction of its aerial parts has been used for treatment of cancer, as an immunostimulant and antioxidant drug. An UHPLC-HRMS profiling method was used for a comprehensive study of flavonoid composition of C. foliosum. Fourty flavonoid glycosides with nine aglycones (patuletin, gomphrenol, spinacetin, 6-methoxykaempferol, kaempferol, quercetin, isorhamnetin, 3,5,3',4'-tetrahydroxy-6,7-methylenedioxyflavone and 3,5,4'-trihydroxy-3'-methoxy-6,7-methylenedioxyflavone) were detected. Kaempferol, quercetin and isorhamnetin glycosides were identified as minor components. A pseudo MS3 experiment aided at discriminating 6-methoxykaempferol and isorhamnetin glycosides. Flavonoid composition dominated by di-, triglycosides and acylated flavonoids. Acid hydrolysis and GS-MS analysis confirmed the presence of D-glucose, D-apiose and L-rhamnose. Ten flavonoids were reported here for the first time.
Keyphrases
- ms ms
- high resolution mass spectrometry
- mass spectrometry
- multiple sclerosis
- liquid chromatography
- single cell
- simultaneous determination
- papillary thyroid
- oxidative stress
- squamous cell carcinoma
- emergency department
- blood pressure
- type diabetes
- squamous cell
- anti inflammatory
- staphylococcus aureus
- solid phase extraction
- pseudomonas aeruginosa
- gas chromatography
- high resolution
- young adults
- escherichia coli
- metabolic syndrome
- adipose tissue